Macronutrients: Complete Guide to Dietary Fats

Comprehensive tutorial on dietary fats - saturated, unsaturated, trans fats, omega-3 and omega-6 fatty acids, cholesterol, digestion, metabolism, food sources, and cardiovascular health. From the NIH, AHA, and USDA.

This content is for informational purposes only. Always consult a healthcare professional.

Overview

Dietary fats (lipids) are the most energy-dense macronutrient, providing 9 kcal per gram. They serve essential structural, hormonal, and metabolic functions. Fats are composed primarily of triglycerides (three fatty acids esterified to a glycerol backbone).

Function Description
Energy provision 9 kcal/g (primary energy reserve)
Energy storage Adipose tissue (triglycerides)
Cell membrane structure Phospholipid bilayer (phospholipids, cholesterol)
Hormone precursors Steroid hormones from cholesterol
Fat-soluble vitamin transport Vitamins A, D, E, K absorption
Insulation Thermal (subcutaneous fat) and electrical (myelin)
Organ protection Visceral fat cushions organs
Satiety Delays gastric emptying, stimulates CCK release
Flavor and texture Contributes to food palatability

Chemical Classification of Fatty Acids

Saturation

Type Carbon Bonds Structure Physical State Examples
Saturated All single bonds (C-C) Straight chain, packs tightly Solid at room temp Butter, coconut oil, animal fat
Monounsaturated (MUFA) One double bond (C=C) Bent chain, packs loosely Liquid at room temp Olive oil, avocado, nuts
Polyunsaturated (PUFA) Two or more double bonds Highly bent Liquid at room temp Vegetable oils, fish oil

Chain Length

Chain Length Carbon Atoms Food Sources
Short-chain (SCFA) 2-4 Produced by gut fermentation of fiber (butyrate, acetate, propionate)
Medium-chain (MCFA) 6-12 Coconut oil (lauric acid C12), palm kernel oil
Long-chain (LCFA) 14-20 Most dietary fats (palmitic C16, stearic C18, oleic C18:1)
Very long-chain (VLCFA) 22+ Fish oil (EPA C20:5, DHA C22:6), brain tissue

Saturated Fatty Acids

Name Carbon Atoms Food Sources
Butyric acid 4:0 Butter (4% of fat), produced by gut bacteria
Caproic acid 6:0 Butter, coconut oil (trace)
Caprylic acid 8:0 Coconut oil (6%), palm kernel oil
Capric acid 10:0 Coconut oil (6%), palm kernel oil
Lauric acid 12:0 Coconut oil (47%), palm kernel oil
Myristic acid 14:0 Butter (11%), coconut oil (18%)
Palmitic acid 16:0 Palm oil (44%), butter (26%), animal fat (25-30%)
Stearic acid 18:0 Cocoa butter (34%), animal fat (15-20%)
Arachidic acid 20:0 Peanut oil (1-2%)

Monounsaturated Fatty Acids (MUFA)

Name Carbon Atoms Double Bond Position Food Sources
Palmitoleic acid 16:1 n-7 Macadamia oil, sea buckthorn, some animal fats
Oleic acid 18:1 n-9 Olive oil (55-83%), avocado (70%), almonds (70%), canola oil (60%)
Gondoleic acid 20:1 n-11 Jojoba oil, mustard oil
Erucic acid 22:1 n-9 Rapeseed (old varieties), mustard (limited in canola by regulation)
Nervonic acid 24:1 n-9 Brain tissue, myelin

Polyunsaturated Fatty Acids (PUFA)

Name Carbon Atoms Double Bond Position Food Sources
Linoleic acid (LA) 18:2 n-6 (Omega-6) Vegetable oils (soybean, corn, sunflower), nuts, seeds
Alpha-linolenic acid (ALA) 18:3 n-3 (Omega-3) Flaxseed, chia seeds, walnuts, canola oil
Gamma-linolenic acid (GLA) 18:3 n-6 Evening primrose oil, borage oil
Arachidonic acid (AA) 20:4 n-6 Meat, eggs, synthesized from LA
Eicosapentaenoic acid (EPA) 20:5 n-3 Fish oil (salmon, mackerel, sardines), algae
Docosahexaenoic acid (DHA) 22:6 n-3 Fish oil, algae, brain/retina

Omega-3 and Omega-6 Fatty Acids

Omega-3 Family

Fatty Acid Chain Conversion Efficiency Key Sources
Alpha-linolenic acid (ALA) 18:3 n-3 (Parent) Flaxseed, chia seeds, walnuts, hemp seeds
Stearidonic acid (SDA) 18:4 n-3 ~30% to EPA Ahiflower oil, genetically modified soybean
Eicosapentaenoic acid (EPA) 20:5 n-3 (Direct from source) Fatty fish (salmon, mackerel, herring, sardines)
Docosahexaenoic acid (DHA) 22:6 n-3 (Direct from source) Fatty fish, algae, fish oil supplements

Conversion of ALA to EPA/DHA: In humans, approximately 5-10% of ALA converts to EPA, and 2-5% converts to DHA. Conversion is inhibited by high omega-6 intake and activated by insulin.

Omega-6 Family

Fatty Acid Chain Key Sources
Linoleic acid (LA) 18:2 n-6 Soybean oil, corn oil, sunflower oil, nuts, seeds
Gamma-linolenic acid (GLA) 18:3 n-6 Evening primrose oil, borage oil, black currant seed oil
Dihomo-gamma-linolenic acid (DGLA) 20:3 n-6 Synthesized from GLA (minor dietary)
Arachidonic acid (AA) 20:4 n-6 Meat, poultry, eggs (synthesized from LA)

Omega-6:Omega-3 Ratio

Diet Type Omega-6:Omega-3 Ratio
Ancestral/hunter-gatherer ~1:1 to 4:1
Standard Western diet ~15:1 to 20:1
Mediterranean diet ~4:1 to 6:1
Current recommendations 4:1 to 5:1

A high omega-6:omega-3 ratio promotes pro-inflammatory states, while a lower ratio is associated with reduced risk of cardiovascular disease, inflammation, and autoimmune conditions.

Trans Fats

Natural vs. Industrial Trans Fats

Type Source Formation Health Effect
Natural (ruminant) Dairy, beef Biohydrogenation in ruminant stomach No adverse effects at typical intake; some may be neutral/beneficial
Industrial (partially hydrogenated oils) Processed foods, fried foods, baked goods Partial hydrogenation of vegetable oils Clearly harmful — increases LDL, decreases HDL, promotes inflammation
Vaccenic acid (natural) Dairy fat (trans-11 18:1) Ruminant biohydrogenation Neutral to beneficial (precursor to CLA)
Conjugated linoleic acid (CLA, natural) Dairy, beef Ruminant biohydrogenation Mixed effects — may have anti-cancer properties in animal models
Elaidic acid (industrial) PHOs, margarine, shortening Partial hydrogenation Clear CVD risk factor

Regulatory Status of Industrial Trans Fats

Jurisdiction Status
United States (FDA) Generally Not Recognized as Safe (GRAS) — phased out by 2020 (with limited exceptions)
European Union Limit of 2 g per 100 g of fat (2021)
Canada Banned in PHOs (2018)
Denmark Effectively zero (first country to ban, 2003)
WHO (REPLACE initiative) Goal: global elimination by 2023

Cholesterol

Types

Lipoprotein Class Composition Apolipoprotein Function
Chylomicrons 90% triglycerides B-48 Transport dietary fat from intestine to tissues
VLDL (Very Low Density) 55% triglycerides B-100 Transport endogenous triglycerides from liver
IDL (Intermediate Density) 30% triglycerides, 25% cholesterol B-100, E VLDL remnant, taken up by liver or converted to LDL
LDL (Low Density) 50% cholesterol B-100 Transport cholesterol to peripheral tissues
HDL (High Density) 50% protein, 20% cholesterol A-I, A-II Reverse cholesterol transport (from tissues to liver)
Lipoprotein(a) [Lp(a)] LDL-like + apo(a) B-100, apo(a) Genetic cardiovascular risk factor

Dietary Cholesterol vs. Blood Cholesterol

Aspect Evidence
Dietary cholesterol effect on blood cholesterol Modest — increases both LDL and HDL; individual variability significant
Hyper-responders ~25% of population — dietary cholesterol significantly raises blood LDL
Hypo-responders ~75% — dietary cholesterol has minimal effect (compensatory downregulation of endogenous synthesis)
Saturated fat effect Much stronger determinant of blood LDL than dietary cholesterol
Eggs and CVD risk Current evidence: no significant association with CVD in most populations (up to 1 egg/day)
2020-2025 USDA Dietary Guidelines No specific limit on dietary cholesterol (removed 300 mg/day limit from 2015 guidelines)
Parameter Desirable Borderline High/Risk
Total cholesterol <200 mg/dL 200-239 mg/dL ≥240 mg/dL
LDL cholesterol <100 mg/dL 130-159 mg/dL ≥160 mg/dL (≥190 mg/dL very high)
HDL cholesterol ≥60 mg/dL 40-59 mg/dL (men) <40 mg/dL (men), <50 mg/dL (women)
Triglycerides <150 mg/dL 150-199 mg/dL ≥200 mg/dL (≥500 mg/dL very high)
Non-HDL cholesterol <130 mg/dL 130-159 mg/dL ≥160 mg/dL

Fat Digestion and Absorption

Digestive Pathway

Site Enzyme/Agent Substrate Product
Mouth Lingual lipase (minor) Short/medium-chain triglycerides Free fatty acids, diglycerides
Stomach Gastric lipase (minor, active at pH 3-6) Triglycerides (especially MCT) Free fatty acids, diglycerides
Small intestine (lumen) Bile salts (from liver/gallbladder) Fat globules Emulsified fat droplets (micelles)
Small intestine (lumen) Pancreatic lipase Triglycerides 2-monoglyceride + 2 free fatty acids
Small intestine (lumen) Colipase (pancreatic, activates lipase in presence of bile) Facilitates lipase activity
Small intestine (lumen) Phospholipase A₂ Phospholipids Lysophospholipid + free fatty acid
Small intestine (lumen) Cholesterol esterase Cholesteryl esters Cholesterol + free fatty acid
Small intestine (brush border) Micelles deliver to enterocyte Cellular uptake

Absorption and Transport

Step Location Process
Micelle formation Duodenum/jejunum lumen Bile acids surround fat digestion products, forming water-soluble micelles
Uptake into enterocyte Brush border of jejunum Diffusion of free fatty acids, monoglycerides, cholesterol, and fat-soluble vitamins
Resynthesis of triglycerides Smooth ER of enterocyte 2-monoglyceride + 2 fatty acyl-CoA → Triglyceride
Chylomicron formation Golgi apparatus Triglycerides + cholesterol + phospholipids + apolipoprotein B-48
Lymphatic transport Lacteals → Lymphatic system Chylomicrons enter lacteals (not directly into portal blood)
Thoracic duct → Bloodstream Thoracic duct → Subclavian vein Chylomicrons enter systemic circulation
Lipoprotein lipase Capillary endothelium Hydrolyzes chylomicron triglycerides → FFA taken up by tissues
Chylomicron remnant Liver Taken up by liver via apoE receptor

Dietary Recommendations

Fat Intake Recommendations

Organization Total Fat Saturated Fat Unsaturated Fat
USDA/DGA (2020-2025) 20-35% of total calories <10% of total calories Majority from unsaturated
AHA 20-35% of total calories <7% of total calories (or <5-6% for CVD patients) Replace saturated with unsaturated
WHO 15-30% of total calories <10% of total calories (<7% for additional benefit) (Not specified)
IOM (AMDR) 20-35% (adults), 25-40% (children) As low as possible As needed to meet total fat
EFSA 20-35% of total calories <10% of total calories (Not specified)

Specific Fatty Acid Recommendations

Fatty Acid Recommendation Source Recommendation
Total omega-3 (ALA) IOM RDA 1.6 g/day (men), 1.1 g/day (women)
Total omega-3 (EPA + DHA) AHA ≥2 servings fatty fish/week (~500 mg/day EPA+DHA)
Total omega-3 (EPA + DHA) FDA ≤2 g/day from supplements (safety)
Total omega-6 (LA) IOM AI 17 g/day (men), 12 g/day (women)
Trans fat WHO, FDA As low as possible (<1% of total calories)
Industrial trans fat FDA Eliminated from food supply
Dietary cholesterol USDA/DGA 2020-2025 No specific limit (eat as little as possible while maintaining healthy diet)

Food Sources

Saturated Fat Content by Food

Food Serving Total Fat (g) Saturated Fat (g) SFA as % of Total
Coconut oil 1 tbsp (14 g) 14 12 86%
Butter 1 tbsp (14 g) 12 7.5 63%
Palm oil 1 tbsp (14 g) 14 6.7 48%
Heavy cream 1 tbsp (15 g) 5.5 3.5 64%
Cheddar cheese 30 g 9 6 67%
Bacon (cooked) 3 slices (35 g) 13 4.5 35%
Beef (80/20, cooked) 100 g 16 6 38%
Chicken thigh (skin-on) 100 g 16 4.5 28%
Salmon (farm-raised) 100 g 13 3 23%
Avocado 100 g 15 2.1 14%
Egg (whole) 1 large (50 g) 5 1.6 32%

MUFA Content by Food

Food Serving Total Fat (g) MUFA (g)
Olive oil 1 tbsp (14 g) 14 10
Canola oil 1 tbsp (14 g) 14 9
Avocado 100 g 15 10
Almonds 30 g (23 nuts) 15 9.5
Cashews 30 g (18 nuts) 12 7
Peanuts 30 g 14 7
Pecans 30 g (19 halves) 20 12
Macadamia nuts 30 g (10-12 nuts) 22 17
Lard 1 tbsp (13 g) 13 6
Pork tenderloin (cooked) 100 g 4 1.5

PUFA Content by Food

Food Serving Total Fat (g) PUFA (g) Omega-3 (g) Omega-6 (g)
Salmon (wild, cooked) 100 g 11 3.5 1.8 EPA+DHA 0.3
Sardines (canned) 100 g 11 4 1.8 EPA+DHA 0.3
Mackerel (cooked) 100 g 14 4 1.6 EPA+DHA 0.2
Herring (pickled) 100 g 10 3 1.5 EPA+DHA 0.2
Flaxseed (ground) 1 tbsp (7 g) 4 3 2.3 ALA 0.6
Chia seeds 1 tbsp (12 g) 5 4 2.5 ALA 1.2
Walnuts 30 g (14 halves) 18 14 2.7 ALA 10.5
Soybean oil 1 tbsp (14 g) 14 8 0.9 ALA 6.7
Corn oil 1 tbsp (14 g) 14 8 0.1 ALA 7.5
Sunflower oil 1 tbsp (14 g) 14 5 0 5
Hemp seeds 3 tbsp (30 g) 15 11 2.5 ALA 8.5

Fats and Health

Cardiovascular Disease

Dietary Factor Effect on LDL Effect on HDL Effect on Triglycerides Net CVD Risk
Saturated fat (C12:0-C16:0) ↑↑ ↓→ ↑ (moderate)
Stearic acid (C18:0) Neutral
MUFA (oleic acid)
PUFA omega-6 (LA) ↓↓ ↓→
PUFA omega-3 (EPA+DHA) ↑ (mild, sometimes) ↓↓↓ ↓↓
Industrial trans fat ↑↑↑ ↓↓ ↑↑↑
Dietary cholesterol ↑ (modest, variable) ↑ (modest) Neutral in most

Omega-3 Health Effects

Condition Effect Evidence Level
Hypertriglyceridemia ↓ Triglycerides 20-50% (dose-dependent) Strong (FDA-approved)
Cardiovascular mortality ↓ Risk, especially sudden cardiac death Strong
Heart failure ↓ Risk (moderate intake) Moderate
Atrial fibrillation Mixed (may ↓ risk at moderate intake, possible ↑ at very high intake) Mixed
Rheumatoid arthritis ↓ Joint pain, morning stiffness Strong
Depression ↓ Symptoms (adjunctive therapy) Moderate
Dementia / cognitive decline ↓ Risk (observational), mixed (RCT) Moderate
Age-related macular degeneration ↓ Risk Moderate
Asthma ↓ Inflammation, mixed clinical outcomes Weak-Moderate
Insulin sensitivity Minimal effect (high dose may slightly improve) Weak

Inflammation and Eicosanoids

Fatty Acid Eicosanoid Effect Inflammatory Potential
Omega-6 (AA) Pro-inflammatory series 2 prostaglandins, series 4 leukotrienes Pro-inflammatory (balanced with omega-3)
Omega-3 (EPA) Anti-inflammatory series 3 prostaglandins, series 5 leukotrienes, resolvins Anti-inflammatory
Omega-3 (DHA) Resolvins, protectins, maresins Pro-resolving (actively resolves inflammation)

Medium-Chain Triglycerides (MCTs)

Property MCTs LCTs
Chain length 6-12 carbons 14-22 carbons
Digestion Rapid (no bile/pancreatic lipase needed) Requires bile and pancreatic lipase
Absorption Direct to portal vein Via chylomicrons → lymph
Energy density 8.3 kcal/g 9 kcal/g
Ketogenic potential High Low
Common sources Coconut oil, palm kernel oil Most dietary fats

Key Takeaways

  • Fats provide 9 kcal/g and are essential for cell membranes, hormones, and vitamin absorption
  • Saturated fat should be <10% of total calories; replace with unsaturated fats for cardiovascular benefit
  • Industrial trans fats should be effectively zero (banned in US, EU, and many countries)
  • Omega-3 fatty acids (EPA/DHA) from fatty fish (≥2 servings/week) reduce CVD risk
  • Omega-6 fatty acids are essential but Western diets have an imbalanced omega-6:omega-3 ratio (~15:1 vs. recommended 4:1)
  • Dietary cholesterol has modest effects on blood cholesterol in most people; eggs are not associated with CVD risk
  • Total fat should comprise 20-35% of total calories, with the majority from unsaturated sources
  • Fat digestion involves emulsification (bile), hydrolysis (lipases), micelle formation, and chylomicron transport via lymphatics